Ad
related to: ino stock news
Search results
Results From The WOW.Com Content Network
Inovio's net loss for the third quarter of 2024 was $25.2 million, or $0.89 per share, basic and dilutive, compared to a net loss of $33.9 million, or $1.52 per share, basic and dilutive, for the ...
Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q2 2024 Earnings Call Aug 08, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
If there's one thing that traders have learned about Inovio Pharmaceuticals (NASDAQ:INO) stock, it's that half a year can make a huge difference. Biotechnology stocks can be fast movers, sure, but ...
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, ... "Inovio Pharmaceuticals, Inc. Common Stock (INO) News Headlines ...
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading.
The more important question is: Why have Inovio's shares fallen for several weeks now?